LEGISLATION
The Sackler Case Comes to a Close; Final Analysis and the Importance of Holding Pharma Companies Accountable
Consider this: Purdue Pharmaceuticals/the Sacklers versus thousands of plaintiffs nationwide. It was one of the most closely watched pharmaceutical litigations of our time, and it just came to a close. While there were some small victories in the case, many see its outcome as a loss for those who suffered at the hands of Purdue’s addictive opioid painkiller, OxyContin.
Decriminalization Not a Silver Bullet For Americans, Part 1
With Oregon being the first state to decriminalize all drugs, it's time to look at how decriminalization can—or can't—be done in a way that does NOT increase deaths resulting from drug abuse. Part one of a two-part series.
More States Move to Legalize Cannabis
The Presidential race was not the only attention-grabbing aspect of the November 2020 election. In an historic move, several states, even red states, moved to legalize cannabis for recreational use. What does this mean for the health of those states' populations? And for the future?
What Legalizing Drugs Will Do to Perceived Risk and Young Adult Drug Use
Oregon’s recent legalization of psychedelics for medicinal use raises many questions about the sense (or lack thereof) in legalizing mind-altering drugs, even for medicinal purposes.
Oregon Decriminalizes Drugs—What This Means for the Future
In an effort to keep addicts out of jail, Oregon just voted to decriminalize possession of heroin, methamphetamine, LSD, oxycodone, and other hard drugs. However, many criticize the law for legalizing harmful substances.
What Was Johnson & Johnson's Role in Triggering the Opioid Epidemic?
Oklahoma's lawsuit against Johnson & Johnson revealed the role this company played in encouraging the too-liberal use of opioid painkillers. Witness testimony also pointed to the special way this company profited from increased prescribing – of their own drugs or even drugs from other companies.
Suboxone Maker to Pay $1.4 BILLION to Settle Illegal Marketing Claims
In July 2019, Pharmaceutical company Reckitt Benckiser Group settled a federal lawsuit that they fraudulently marketed their addiction treatment drug Suboxone. They’ll pay a huge fine but why doesn’t this settlement actually result in justice?
Tide Turns On Pharmaceutical Industry As Leading Advocate Changes Mind On Pain Medication
An article in the New York Times from April 29th, 2019 shone a light on the opioid addiction crisis and highlighted a phenomenon we are very glad to see. Medical doctors, usually pain pill advocates, are turning their backs on pharmaceutical opioids and are making a stand against the very companies that manufacture them.
Makers of Fentanyl Under Fire for Bribing Doctors
There’s something special and even a little energizing when the bad guy finally gets caught. When the underdog hero somehow manages to win against insurmountable odds.
Drug Court Vs. Treatment: How Drug Courts Can Help | Narconon
In a nation that struggles with a drug addiction epidemic, our society rapidly seeks solutions and methodology for reducing the drug problem.
NARCONON NEWS
In a Landscape Plagued by Drugs and Violence, Narconon Puebla is a Bright Ray of Hope
Narconon Centers
•
Puebla, Mexico
New Study Shows Further Scientific Evidence for Narconon Drug and Alcohol Rehabilitation Program
Studies and Reports
•
United States
